Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 542 results for "cadila healthcare"

Bank of Baroda, Union Bank results in focus
India Infoline

Here's why Canara Bank, pharma cos, Texmaco Rail are in news

Some of the stocks that should be on your radar are: Axis Bank, NCC, Canara Bank, State Bank of Mysore, Cadila Healthcare, Cipla, PNC Infratech, Sun Pharma Advanced Research Company, Sun Pharmaceutical Industries, Dr Reddys Laboratories, Texmaco Rail and ... Money Control, 2 days ago
Bank of Baroda, Union Bank results in focus India Infoline, 2 months ago

68 images for cadila healthcare

India Infoline, 2 weeks ago
India Infoline, 2 weeks ago
Financial Express, 2 weeks ago
Business Standard India, 2 weeks ago
India Infoline, 1 month ago
Business Standard India, 2 weeks ago
Indian Express, 1 month ago
DNA, 2 weeks ago
Business Standard India, 1 month ago
VC Circle, 1 month ago

Zydus To Sell Ulcerative Colitis Treatment Generic Drug In US Market

Representational image New Delhi : Drug firm Cadila Healthcare's USarm Zydus Pharmaceuticals (USA) Inc will start selling ageneric version of Asacol HD, used for treatment of ulcerativecolitis, in the American market from August 1, 2016. ...
 NDTV1 week ago Zydus to sell Asacol HD's generic in US market  Business Standard1 week ago

Outperform Cadila Healthcare Ltd., target Rs 405: Credit Suisse

Credit Suisse has an outperform call on Cadila Healthcare Ltd. with a target price of Rs 405. The current market price of Cadila Healthcare Ltd. is Rs 364.5. Time period given by analyst is year, when Cadila Healthcare Ltd. price can reach defined ...
 Economic Times2 weeks ago Overweight Cadila Healthcare Ltd., target Rs 399 : Morgan Stanley  Economic Times2 weeks ago

CADILA HEALTHCARE : Patent Issued for Polymorphic Forms of Ivabradine Hydrochloride (USPTO 9382209)

By a News Reporter-Staff News Editor at Journal of Engineering -- According to news reporting originating from Alexandria, Virginia, by VerticalNews journalists, a patent by the inventors Dwivedi, Shriprakash Dhar (Gujarat, IN); Prasad, Ashok ...
 4 Traders1 week ago

Weekly Wrap: Sensex, Nifty gain over 2.5% on global cues

Indian stock indices vaulted to 11-month closing highs last week (July 11 - 15, 2016), as the mood remained bullish for most part of the week, riding on strong global markets on the back of encouraging U.S. jobs data and hopes about monetary easing in several ...
 Sify1 week ago

Wealth in wellness

Papaya face masks and herbal sweeteners now share space with antibiotics, as Gujarat's major pharmaceutical companies have included herbal and wellness products to their repertoire. It's not just about painkillers and antibiotics for ...
 India Today1 week ago

Folate Market Segments and Forecast By End-use Industry 2016-2026

Folate, also known as vitamin B9, is most noted for its role in supporting a healthy pregnancy and fetal development. It is a synthetic folate compound used in vitamin supplements and fortified food because of its increased stability. It is also ...
 MyNewsDesk1 week ago Folate Market Revenue, Opportunity, Forecast and Value Chain 2016-2026  MyNewsDesk4 weeks ago

Which sectors are on fund managers radar?

The recent data released by Sebi shows that the mutual funds have deployed Rs.90,014 crore in bank stocks, which is 20.28% of their equity AUM, in May 2016. Similarly, software stocks attracted Rs.42,372 crore (9.5% of equity AUM), followed by ...
 India Infoline2 weeks ago

CADILA HEALTHCARE : Fda nod for zydus' anti-diabetic drug

Cadila Healthcare Ltd (Zydus Cadila) has received the approval of the US Food and Drug Administration (FDA) for its anti-diabetic drug. The company will market Nateglinide tablets in strengths of 60 mg and 120 mg in the US. Cadila intends to ...
 4 Traders2 weeks ago Cadila Healthcare: More triggers awaited  Business Standard2 weeks ago Cadila Healthcare jumps 4%; sees US and LatAm as key markets  India Infoline2 weeks ago Cadila Healthcare jumps after USFDA approval for anti-diabetic drug  Business Standard2 weeks ago
India Infoline

Views on Cadila Healthcare - USFDA update - Angel Broking

Posted On: 2016-07-08 21:52:59 Ms. Sarabjit Kour Nangra (VP Research - Pharma, Angel Broking) on Cadila Healthcare - USFDA update: "Company's Moraiya manufacturing facility has received an Establishment Inspection Report (EIR) from the USFDA.
 Equity Bulls2 weeks ago Zydus Wellness steps on gas: plans Everyuth re-launch, eyes buy-outs  Smart Investor1 month ago Cadila to acquire two drug forms from Teva to strengthen its US portfolio  Domain-B1 month ago Cadila Healthcare ends in green; buys two ANDAs from Teva  India Infoline1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - cadila healthcare
Get updated on latest news & your favorite topics right in your inbox!
More     Less